Understand the source comparison
SS-31 for Exercise Performance: Research-Grade Peptide Comparison
SS-31 (Elamipretide) Cardiolipin stabilization, electron transport chain efficiency, ROS reduction ATP/ADP ratio (+18–24%), sustained power output (+6–8%), recovery time (−30–40%) Pre-workout or daily ≥98% via HPLC Gold standard for mitochondrial protection un
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SS-31 (Elamipretide)
- Cardiolipin stabilization, electron transport chain efficiency, ROS reduction
- ATP/ADP ratio (+18–24%), sustained power output (+6–8%), recovery time (−30–40%)
- Pre-workout or daily
- ≥98% via HPLC
- Gold standard for mitochondrial protection under oxidative stress. Targets root cause of fatigue
- MOTS-c
- Mitochondrial-derived peptide, AMPK activation, metabolic regulation
- Glucose uptake (+15–20%), endurance time to exhaustion (+12%)
- Daily or 3×/week
- ≥95% via HPLC
- Complements SS-31 for metabolic flexibility but lacks direct ETC stabilization
- Humanin
- Mitochondrial cytoprotection, anti-apoptotic signaling
- Recovery markers (CK −25%), neuroprotection
- Daily
- Protective but weaker performance impact. Better suited for recovery than acute output
- NAD+ precursors (NMN/NR)
- NAD+ repletion, sirtuin activation
- Mitochondrial biogenesis markers (+10–15%), subjective energy
- Daily oral
- ≥99% via HPLC
- Supports long-term mitochondrial health but slower mechanism. Weeks vs hours for SS-31
- SS-31 for exercise performance stands apart because it acts within hours and targets the exact failure point during sustained effort: electron transport chain integrity under oxidative load. MOTS-c Peptide works through metabolic signaling over days to weeks, while SS-31 stabilizes the machinery generating ATP right now.